Prognostic outcomes in advanced breast cancer: the metastasis-free interval is important
Authors:
- 1 December 2017
- journal article
- research article
- Published by Elsevier in Human Pathology
- Vol. 70, 70-76
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Prognostic factors in patients with metastatic breast cancer at the time of diagnosisPathology - Research and Practice, 2014
- Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapyThe Breast, 2013
- Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcomeBreast Cancer Research and Treatment, 2013
- The Implications of Clonal Genome Evolution for Cancer MedicineNew England Journal of Medicine, 2013
- Prognostic factors for stage IV hormone receptor-positive primary metastatic breast cancerBreast Cancer, 2011
- Factors associated with mortality after breast cancer metastasisCancer Causes & Control, 2011
- Survival differences among women with de novo stage IV and relapsed breast cancerAnnals of Oncology, 2010
- Trends in Survival Over the Past Two Decades Among White and Black Patients With Newly Diagnosed Stage IV Breast CancerJournal of Clinical Oncology, 2008
- Prognostic factors in 1038 women with metastatic breast cancerAnnals of Oncology, 2008
- Survival of patients with metastatic breast carcinomaCancer, 2003